» Articles » PMID: 36570971

Disseminated Tuberculosis With an Atypical Cutaneous Manifestation in a Hematopoietic Cell Transplant Patient in the Early Posttransplant Period: Case Report and Review of the Literature

Overview
Date 2022 Dec 26
PMID 36570971
Authors
Affiliations
Soon will be listed here.
Abstract

We describe an unusual case of posttransplant tuberculosis reactivation in a man who underwent allogeneic hematopoietic cell transplant. Concomitant with disseminated adenovirus infection, reactivation of tuberculosis manifested as disseminated, nonfollicular pustules on day +49. Skin biopsy was obtained on day +50. Initial histopathologic evaluation did not suggest mycobacterial infection, but tissue stain showed acid-fast organisms, which were subsequently identified as . Shortly after the cutaneous presentation of tuberculosis, the patient died on day +52. Our case is among a paucity of reports describing tuberculosis reactivation in hematopoietic cell transplant patients in the early posttransplant period. It highlights the difficulty of diagnosing contemporaneous systemic infections, and it presents a rare and atypical cutaneous manifestation of tuberculosis in a hematopoietic cell transplant patient. Our case and review of the literature emphasize the need for further research to elucidate risk factors associated with early posttransplant reactivation of tuberculosis, and the importance of remaining vigilant for active tuberculosis in hematopoietic cell transplant patients with epidemiologic risk factors.

References
1.
Munoz L, Gomila A, Casas S, Castellote J, Arnan M, Rafecas A . Immunodiagnostic Tests' Predictive Values for Progression to Tuberculosis in Transplant Recipients: A Prospective Cohort Study. Transplant Direct. 2016; 1(3):e12. PMC: 4946446. DOI: 10.1097/TXD.0000000000000520. View

2.
Frankel A, Penrose C, Emer J . Cutaneous tuberculosis: a practical case report and review for the dermatologist. J Clin Aesthet Dermatol. 2010; 2(10):19-27. PMC: 2923933. View

3.
Lee Y, Lee S, Choi S, Kim Y, Woo J, Kim D . A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients. J Infect. 2014; 69(2):165-73. DOI: 10.1016/j.jinf.2014.02.019. View

4.
Yang A, Shi J, Luo Y, Ye Y, Tan Y, Huang H . Allo-HSCT recipients with invasive fungal disease and ongoing immunosuppression have a high risk for developing tuberculosis. Sci Rep. 2020; 9(1):20402. PMC: 6938515. DOI: 10.1038/s41598-019-56013-w. View

5.
Benito N, Garcia-Vazquez E, Horcajada J, Gonzalez J, Oppenheimer F, Cofan F . Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study. Clin Microbiol Infect. 2015; 21(7):651-8. DOI: 10.1016/j.cmi.2015.03.010. View